MCL coexpression mm9:932
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr12:25257265..25257294,+ | p2@Grhl1 |
Mm9::chr12:25257298..25257323,+ | p5@Grhl1 |
Mm9::chr12:25257443..25257454,+ | p@chr12:25257443..25257454 + |
Mm9::chr13:40826961..40827001,- | p4@Tfap2a |
Mm9::chr13:40827030..40827039,- | p12@Tfap2a |
Mm9::chr16:25802129..25802142,+ | p3@Trp63 |
Mm9::chr1:162180221..162180250,- | p@chr1:162180221..162180250 - |
Mm9::chr1:52784099..52784112,- | p5@Mfsd6 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0060157 | urinary bladder development | 0.00712211691228839 |
GO:0007499 | ectoderm and mesoderm interaction | 0.00712211691228839 |
GO:0048745 | smooth muscle development | 0.0128170009285442 |
GO:0030859 | polarized epithelial cell differentiation | 0.0128170009285442 |
GO:0001736 | establishment of planar polarity | 0.0128170009285442 |
GO:0007164 | establishment of tissue polarity | 0.0128170009285442 |
GO:0002347 | response to tumor cell | 0.0128170009285442 |
GO:0010464 | regulation of mesenchymal cell proliferation | 0.0128170009285442 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 0.0128170009285442 |
GO:0010463 | mesenchymal cell proliferation | 0.0128170009285442 |
GO:0001738 | morphogenesis of a polarized epithelium | 0.0142403317223895 |
GO:0030308 | negative regulation of cell growth | 0.0153344811757127 |
GO:0031069 | hair follicle morphogenesis | 0.0153344811757127 |
GO:0003700 | transcription factor activity | 0.0179945999811227 |
GO:0045792 | negative regulation of cell size | 0.0180337993848102 |
GO:0030216 | keratinocyte differentiation | 0.0204637457246617 |
GO:0045926 | negative regulation of growth | 0.0209336305578342 |
GO:0042475 | odontogenesis of dentine-containing teeth | 0.0244718933920709 |
GO:0030855 | epithelial cell differentiation | 0.0244718933920709 |
GO:0042476 | odontogenesis | 0.0244718933920709 |
GO:0022404 | molting cycle process | 0.0244718933920709 |
GO:0001942 | hair follicle development | 0.0244718933920709 |
GO:0022405 | hair cycle process | 0.0244718933920709 |
GO:0042633 | hair cycle | 0.0244718933920709 |
GO:0042303 | molting cycle | 0.0244718933920709 |
GO:0007498 | mesoderm development | 0.0254019884354623 |
GO:0048730 | epidermis morphogenesis | 0.0254019884354623 |
GO:0007219 | Notch signaling pathway | 0.0254019884354623 |
GO:0048729 | tissue morphogenesis | 0.0339951142558933 |
GO:0006916 | anti-apoptosis | 0.0339951142558933 |
GO:0001655 | urogenital system development | 0.0339951142558933 |
GO:0001558 | regulation of cell growth | 0.0339951142558933 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.0339951142558933 |
GO:0006351 | transcription, DNA-dependent | 0.0339951142558933 |
GO:0032774 | RNA biosynthetic process | 0.0339951142558933 |
GO:0003677 | DNA binding | 0.0339951142558933 |
GO:0016049 | cell growth | 0.0339951142558933 |
GO:0008544 | epidermis development | 0.0339951142558933 |
GO:0045449 | regulation of transcription | 0.0339951142558933 |
GO:0003682 | chromatin binding | 0.0339951142558933 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0339951142558933 |
GO:0007398 | ectoderm development | 0.0339951142558933 |
GO:0006350 | transcription | 0.0339951142558933 |
GO:0008361 | regulation of cell size | 0.0345388012483832 |
GO:0010468 | regulation of gene expression | 0.0347026954525265 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0352127502353597 |
GO:0031323 | regulation of cellular metabolic process | 0.0352127502353597 |
GO:0002009 | morphogenesis of an epithelium | 0.0352127502353597 |
GO:0007275 | multicellular organismal development | 0.0352127502353597 |
GO:0019222 | regulation of metabolic process | 0.0352127502353597 |
GO:0006917 | induction of apoptosis | 0.0352127502353597 |
GO:0012502 | induction of programmed cell death | 0.0352127502353597 |
GO:0016070 | RNA metabolic process | 0.0361708086362291 |
GO:0040008 | regulation of growth | 0.0382507329653004 |
GO:0043066 | negative regulation of apoptosis | 0.0382507329653004 |
GO:0043069 | negative regulation of programmed cell death | 0.0382507329653004 |
GO:0043065 | positive regulation of apoptosis | 0.0398958467286218 |
GO:0043068 | positive regulation of programmed cell death | 0.0398958467286218 |
GO:0007517 | muscle development | 0.0398958467286218 |
GO:0008284 | positive regulation of cell proliferation | 0.0411514437931659 |
GO:0000074 | regulation of progression through cell cycle | 0.0411514437931659 |
GO:0001501 | skeletal development | 0.0411514437931659 |
GO:0010467 | gene expression | 0.0435781569476487 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.043610113538687 |
GO:0003676 | nucleic acid binding | 0.0443000978803313 |
GO:0009607 | response to biotic stimulus | 0.044849721980422 |
GO:0032502 | developmental process | 0.0457746405621668 |
GO:0007389 | pattern specification process | 0.0477743066906491 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0477743066906491 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0477743066906491 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |